Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-038582

Chief Development Officer sold 5,887 shares at an average $15.04 ($88,565)

  • Chief Development Officer acquired 4,687 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Curley Joanne · Chief Development Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-17 Exercise or conversion : show line 1 in the form +1,346 $6.37 $8,578 26,540 D
2022-06-17 Sale : show line 2 in the form −1,346 $15.08 $20,294 25,194 D
2022-06-17 Exercise or conversion : show line 3 in the form +3,341 $2.90 $9,678 28,535 D
2022-06-17 Sale : show line 4 in the form −3,341 $15.03 $50,211 25,194 D
2022-06-17 Sale : show line 5 in the form −1,200 $15.05 $18,061 23,994 D
Open-market sales · 5,887 sh · avg $15.04 · $88,565

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-06-17 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −1,346 24,145 D
2022-06-17 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −3,341 62,681 D
Loading xslF345X03/doc4.xml…